Alan Meholick
Cardiovascular Disease · Buffalo, NYNPI 1912973025
Payments from drug & device makers
Across 89 payments — averaging $2968.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$185K
- CSL Behring$77K
- Janssen Research & Development, LLC$1K
- E.r. Squibb & Sons, L.L.C.$649
- Johnson & Johnson$101
- Amarin Pharma, Inc.$73
- plus $105 from 3 others
What the payments were for
- Food & beverage$472100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 33 | $184,680 |
| CSL Behring | 34 | $77,331 |
| Janssen Research & Development, LLC | 1 | $1,250 |
| E.r. Squibb & Sons, L.L.C. | 3 | $649 |
| Johnson & Johnson | 6 | $101 |
| Amarin Pharma, Inc. | 5 | $73 |
| Novartis | 4 | $59 |
| Regeneron Healthcare Solutions, Inc. | 2 | $29 |
| Actelion Pharmaceuticals US, Inc. | 1 | $17 |
How this compares
$264,188 in reported general payments places this provider in the 95th percentile of 2,302 cardiovascular disease providers in New York.
Other cardiovascular disease in Buffalo
- Saurabh MalhotraBuffalo$452K
- James MinNew York$41.1M
- Robert RosensonNew York$6.9M
- Roxana MehranNew York$6.4M
- Roger HajjarNew York$5.2M
- Philippe GenereuxNew York$4.4M
- Vijay IyerAmherst$4.3M
- Gregg StoneNew York$3.7M
- Szilard VorosStony Brook$3.7M
- Valentin FusterNew York$2.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.